This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines to the Defense Logistics Agency (DLA). The contract, valued at $12,592.80, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,592.80 and an ultimate completion date of November 14, 2024. It is a firm fixed price delivery order contract. The award is not associated with a...
This federal contract award is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product to the Defense Logistics Agency (DLA). The contract, awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office division, has a ceiling value of $7,431.64 and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant single-award Indefinite...
This federal contract award is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, which is a vaccine. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $10,120.35 and has an ultimate completion date of October 25, 2024. This contract is not associated with a set-aside designation,...
This federal contract award is for the procurement of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $108,043.14 and an ultimate completion date of May 15, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical vaccine product. The award, with a ceiling value of $4,495.66, is a firm fixed-price delivery order contract with an ultimate completion date of August 6, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, as the prime contractor, will be...
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2023, with a ceiling value of $29,286.50 and a completion date of February 27, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award, valued at $97,627.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, and has a completion date of March 7, 2025. This contract award is not designated as a set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,585.15, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,224.50 firm-fixed-price delivery order is for the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with an ultimate completion date of May 30, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $206,110.62, is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product. The contract has an ultimate completion date of November 6, 2024 and is structured as a firm fixed price delivery order. This award does not have a set-aside designation, indicating open competition....